Last week, the U.S. Food and Drug Administration granted emergency use authorization for the use of convalescent plasma for the treatment of COVID-19.
from WebMD Health https://ift.tt/2EQX1Zf
Last week, the U.S. Food and Drug Administration granted emergency use authorization for the use of convalescent plasma for the treatment of COVID-19.
Since the pandemic began, the prevalence of depression symptoms has roughly tripled, with the poor who lost jobs and savings most affected, researchers report.
Those who said their parents were "almost never" loving were at least six times more likely to engage in high levels of cyberbullying than those who said their parents were "almost always" loving.
The data showed that the use of corticosteroids in the care of these patients cut the death rate (after one month of treatment) by about one-third.